ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,014Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1383

$1.08M Total Retail Price of All Prescriptions

Rank: 47 out of 1383

821 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 821 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

34% of this provider’s 821 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 21,462 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,656 1,025 S3 1 1
SIMVASTATIN 1,368 1,027 2 2
AMLODIPINE BESYLATE 1,276 1,137 3 6
FUROSEMIDE 863 702 4 7
OMEPRAZOLE 862 705 5 5
POTASSIUM CHLORIDE 757 615 6 12
LEVOTHYROXINE SODIUM 756 638 7 4
LISINOPRIL 750 576 8 3
METFORMIN HCL 546 398 9 8
RANITIDINE HCL 526 356 10 19
METOPROLOL TARTRATE 509 445 11 9
GABAPENTIN 435 308 12 11
FAMOTIDINE 401 317 13 61
TRAZODONE HCL 372 256 14 36
WARFARIN SODIUM 354 281 15 13
DONEPEZIL HCL 310 310 16 35
LOSARTAN POTASSIUM 295 238 17 23
CLOPIDOGREL 287 228 18 28
TAMSULOSIN HCL 264 240 19 30
KLOR-CON 10 257 161 20 74
CLONIDINE HCL 247 174 21 44
PRAVASTATIN SODIUM 241 182 22 14
ISOSORBIDE MONONITRATE ER 240 208 23 66
HYDROCHLOROTHIAZIDE 240 215 23 10
AMLODIPINE BESYLATE-BENAZEPRIL 238 155 25 68
MELOXICAM 236 182 26 20
POLYETHYLENE GLYCOL 3350 226 198 27 64
CITALOPRAM HBR 225 157 28 15
GLIMEPIRIDE 222 150 29 31
ALLOPURINOL 212 161 30 33
CEFUROXIME 205 162 31 164
ATENOLOL 201 172 32 16
SERTRALINE HCL 197 163 33 21
NAPROXEN 194 154 34 105
PLAVIX 187 160 35 43
LANTUS 185 140 36 50
AZITHROMYCIN 185 132 36 41
PROAIR HFA 184 111 38 42
TRIAMTERENE-HCTZ 181 137 39 48
CARVEDILOL 178 139 40 24
INSULIN SYRINGE 172 105 41 83
CYCLOBENZAPRINE HCL 161 42 R 42 69
RISPERIDONE 159 149 43 71
GEMFIBROZIL 154 109 44 90
PROMETHAZINE HCL 150 81 R 45 56
DIGOXIN 150 135 45 59
DICLOFENAC SODIUM 149 68 47 114
TRAMADOL HCL 148 93 48 25
PREDNISONE 133 103 49 40
IPRATROPIUM-ALBUTEROL 132 132 50 138
OXYBUTYNIN CHLORIDE 132 124 50 115
FENTANYL 130 118 S2 52 92
GLYBURIDE 127 78 R 53 46
MIRTAZAPINE 127 115 53 51
BENAZEPRIL HCL 122 119 55 38
LOVASTATIN 118 68 56 22
NEXIUM 116 72 57 26
CIPROFLOXACIN HCL 115 96 58 54
MECLIZINE HCL 112 101 59 113
ZOLPIDEM TARTRATE 112 75 59 17
ESCITALOPRAM OXALATE 110 96 61 99
FLUTICASONE PROPIONATE 108 93 62 39
NABUMETONE 104 71 63 156
NAMENDA 103 103 64 49
AMOX TR-POTASSIUM CLAVULANATE 99 62 65 106
HYDRALAZINE HCL 98 92 66 86
PANTOPRAZOLE SODIUM 97 89 67 32
QUINAPRIL HCL 94 79 68 142
AMITRIPTYLINE HCL 92 62 R 69 57
CLOTRIMAZOLE-BETAMETHASONE 91 79 70 205
NIFEDIPINE ER 90 82 71 126
ROPINIROLE HCL 89 39 72 79
TERAZOSIN HCL 89 61 72 111
DIOVAN 87 73 74 58
LYRICA 87 36 74 72
METOPROLOL SUCCINATE 86 74 76 29
ATORVASTATIN CALCIUM 85 68 77 18
SPIRIVA 84 52 78 45
NOVOLOG MIX 70-30 82 59 79 273
DIVALPROEX SODIUM 81 72 80 78
CYMBALTA 80 47 81 53
ACTOS 79 66 82 143
METOCLOPRAMIDE HCL 78 54 83 127
PHENYTOIN SODIUM EXTENDED 77 55 84 137
ZETIA 77 49 84 101
SPIRONOLACTONE 75 43 86 67
GLIPIZIDE 72 55 87 98
VENTOLIN HFA 71 38 88 93
PREMARIN 71 65 R 88 123
NOVOLIN R 69 59 90 167
VERAPAMIL ER 67 67 91 84
JANUVIA 66 49 92 85
HUMULIN 70-30 66 44 92 218
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 53 94 27
LOSARTAN-HYDROCHLOROTHIAZIDE 64 53 95 60
NITROGLYCERIN PATCH 63 59 96 177
DILTIAZEM 24HR CD 63 62 96 95
CLINDAMYCIN HCL 62 39 98 267
HUMULIN R 61 48 99 215
ENALAPRIL MALEATE 61 61 99 75
LACTULOSE 60 52 101 128
IBUPROFEN 60 45 101 91
CARISOPRODOL 60 0 R 101 76
ALENDRONATE SODIUM 60 60 101 37
DIOVAN HCT 59 52 105 103
ENDOCET 59 0 S2 105 97
SINGULAIR 54 26 107 82
QUETIAPINE FUMARATE 54 44 107 70
ENABLEX 53 49 109 253
PRIMIDONE 53 53 109 207
SYNTHROID 52 43 111 73
ADVAIR DISKUS 52 43 111 63
CEPHALEXIN 52 45 111 87
DOXAZOSIN MESYLATE 52 52 111 120
MUPIROCIN 51 39 115 189
METFORMIN HCL ER 51 48 115 47
FLUOXETINE HCL 50 19 117 52
METOLAZONE 50 40 117 221
NYSTATIN 50 38 117 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.